Skip to main content
. 2006 Dec 27;81(6):2635–2645. doi: 10.1128/JVI.02316-06

TABLE 2.

Hemagglutination inhibition titers from antigenic analysis of influenza A H9N2 viruses

Virus Genotype Titer with the indicated MAb raised against:
Qa/HK/G1/97
Dk/HK/Y280/97
Ck/HK/G9/97
1073-9 26 29 7B10 8C4 15F1 18G4 3D11 4G3 19A10 18B10 2F4 18B1 G9-6 G9-25
Qa/HK/G1/97 A0 <a >12,800 >12,800 < < < < < < < < < < >12,800 >12,800
Dk/HK/Y280/97 B0 < 400 >12,800 >12,800 >12,800 >12,800 100 100 100 100 6,400 >12,800 >12,800 >12,800 >12,800
Ck/HK/G9/97 Bn < 200 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 1,600 >12,800 6,400 >12,800 >12,800 >12,800 >12,800
WDk/ST/4808/01 B7 < < < 200 >12,800 < < 100 < < 3,200 < < < <
HK/1073/99 A0 100 >12,800 >12,800 < < < 200 < < < 100 < < >12,800 >12,800
HK/2108/03 B7 < < < 200 >12,800 < < < < < 3,200 < < < <
Qa/ST/782/00 A0 100 >12,800 >12,800 < < < < < < < < < < >12,800 >12,800
Qa/ST/2816/00 A1 < >12,800 >12800 < < < < < < < < < < >12800 >12800
Qa/ST/1242/01 A2 800 >12,800 >12,800 < < < 100 < < < 100 < < >12,800 >12,800
Qa/ST/11195/05 A3 3200 >12,800 >12,800 < < < < < < < 200 < < >12,800 >12,800
Qa/ST/3851/02 A3 100 < >12,800 < < < < < < < 100 < < < <
Qa/ST/3308/03 A3 800 < >12,800 200 < < < < < < 200 < < < <
Qa/ST/403/04 A3 < < 12,800 < < < < < < < < < < < <
Qa/ST/243/00 B1 200 < < 200 >12,800 < < < < < 400 < < 100 <
Qa/ST/1318/00 B2 < < < < 1,600 < < < < < 1,600 < < < <
Qa/ST/1425/01 B5 200 < < 400 >12,800 < < < < < 6,400 < 200 < <
Qa/ST/4762/01 B6 200 < < 400 >12,800 < < < < < 6,400 < < < <
Qa/ST/365/02 B8 200 < < 400 >12,800 < < < < < 6,400 < 200 < <
Qa/ST/1038/02 B9 3200 < < 400 >12,800 < < < < < 6,400 < < < <
Qa/ST/1780/03 B10 100 < < 200 >12,800 < < < < < 3,200 < < < <
Qa/ST/15892/05 B16 < < 400 200 >12,800 < 100 100 < 100 6,400 100 400 < <
Qa/ST/1820/00 B3 400 1,600 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 6,400 >12,800 >12,800 >12,800 >12,800
Qa/ST/850/01 B3 1600 3,200 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800
Qa/ST/1158/01 B4 100 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800
Qa/ST/5663/01 B7 800 800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 6,400 >12,800 >12,800 >12,800 >12,800
Qa/ST/2615/03 B11 400 < 800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 3,200 >12,800 >12,800 3,200 12,800
Qa/ST/3502/03 B12 < 400 3,200 800 >12,800 >12,800 >12,800 100 100 >12,800 1,600 3,200 1,600 >12,800 >12,800
Qa/ST/4038/03 B13 200 800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 6,400 >12,800 >12,800 >12,800 >12,800
Qa/ST/6046/04 B14 800 800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800
Qa/ST/6794/04 B15 < 100 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 3,200 >12,800 >12,800 >12,800 >12,800
Qa/ST/3143/05 B8 < 100 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 >12,800 3,200 >12,800 >12,800 >12,800 >12,800
a

<, HI titer lower than 100.

HHS Vulnerability Disclosure